<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34946201</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>16</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Primary Site of Coxsackievirus B Replication in the Small Intestines: No Proof of Peyer's Patches Involvement.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2600</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms9122600</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Enterovirus (EV) infections are associated with a broad range of diseases. Since the first experimental infection of primates with poliovirus (PV), tonsils and the Peyer's patches (PPs) have been believed to be the primary replication sites of EVs. Our aim was to localize different viral markers in the small intestines (SI) of coxsackievirus B (CVB) orally and intraperitoneally (i.p.) infected mice.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Transverse sections of SIs of both infected and control male outbred mice were collected at different intervals post-infection (p.i) and analyzed for presence of interferon-alpha (IFN-α) and viral protein VP1 by immunohistochemistry and in situ hybridization (ISH). Fluorescent marker, eGFP, was identified in cryosections of mice infected with eGFP-CVB3.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the infected SIs, we observed enlarged germinating centers (GCs) in the PPs; IFN-α was detected in the PPs and mucosal layer of the SIs. However, VP1, viral RNA and the eGFP were absent in the GCs of PPs at all stages of infection irrespective of the virus strains used.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Virus was present in the epithelial cells but not in GCs of the PPs of the murine SIs. Our results do not support the hypothesis of EV replication in the PP especially in the GCs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bopegamage</LastName><ForeName>Shubhada</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8423-5565</Identifier><AffiliationInfo><Affiliation>Enterovirus Laboratory, Institute of Microbiology, Faculty of Medicine, Slovak Medical University, Limbova 12, 833 03 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berakova</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Martinske Biopticke Centrum s.r.o., V. Spanyola 47A Street, 010 01 Zilina, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomocak</LastName><ForeName>Pavol</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Immunohistochemical Laboratory, Medical Laboratory Pathology and Cytology, Cytopathos, s.r.o., Kutuzovova 23, 831 03 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baksova</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Human Pathogens, Institute of Microbiology, Faculty of Medicine, Slovak Medical University, Limbova 12, 833 03 Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galama</LastName><ForeName>Jochem</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Radboud University Medical Centre, Department of Medical Microbiology, 6525 GA Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyoty</LastName><ForeName>Heikki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Department of Virology, Tampere University, 33100 Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fimlab Laboratories, Pirkanmaa Hospital District, 33521 Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tauriainen</LastName><ForeName>Sisko</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3423-5409</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, University of Turku, 20520 Turku, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SK0082</GrantID><Agency>Project funds Mechanism EEA and Slovak Government</Agency><Country /></Grant><Grant><GrantID>26240120033</GrantID><Agency>Centre of excellence of environmental health, ITMS</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Peyer’s patches</Keyword><Keyword MajorTopicYN="N">coxsackieviruses</Keyword><Keyword MajorTopicYN="N">mice</Keyword><Keyword MajorTopicYN="N">small intestines</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34946201</ArticleId><ArticleId IdType="pmc">PMC8709031</ArticleId><ArticleId IdType="doi">10.3390/microorganisms9122600</ArticleId><ArticleId IdType="pii">microorganisms9122600</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nathanson N. The pathogenesis of poliomyelitis: What we don’t know. Adv. Virus Res. 2008;71:1–50. doi: 10.1016/S0065-3527(08)00001-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(08)00001-8</ArticleId><ArticleId IdType="pubmed">18585526</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodian D. Emerging concept of poliomyelitis infection. Science. 1955;122:105–108. doi: 10.1126/science.122.3159.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.122.3159.105</ArticleId><ArticleId IdType="pubmed">14385825</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie H., Koike S., Kurata T., Sato-Yoshida Y., Ise I., Ota Y., Abe S., Hioki K., Kato H., Taya C. Transgenic mice carrying the human poliovirus receptor: New animal models for study of poliovirus neurovirulence. J. Virol. 1994;68:681–688. doi: 10.1128/jvi.68.2.681-688.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.2.681-688.1994</ArticleId><ArticleId IdType="pmc">PMC236503</ArticleId><ArticleId IdType="pubmed">8289371</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike S., Taya C., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto A. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. USA. 1991;88:951–955. doi: 10.1073/pnas.88.3.951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.3.951</ArticleId><ArticleId IdType="pmc">PMC50932</ArticleId><ArticleId IdType="pubmed">1846972</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike S., Taya C., Aoki J., Matsuda Y., Ise I., Takeda H., Matsuzaki T., Amanuma H., Yonekawa H., Nomoto A. Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene—Influence of the transgene expression on pathogenesis. Arch. Virol. 1994;139:351–363. doi: 10.1007/BF01310797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01310797</ArticleId><ArticleId IdType="pubmed">7832641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohka S., Nomoto A. Recent insights into poliovirus pathogenesis. Trends Microbiol. 2001;9:501–506. doi: 10.1016/S0966-842X(01)02200-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(01)02200-4</ArticleId><ArticleId IdType="pubmed">11597452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson J.M., Krithivas A., Celi L., Droguett G., Horwitz M.S., Wickham T., Crowell R.L., Finberg R.W. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J. Virol. 1998;72:415–419. doi: 10.1128/JVI.72.1.415-419.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.1.415-419.1998</ArticleId><ArticleId IdType="pmc">PMC109389</ArticleId><ArticleId IdType="pubmed">9420240</ArticleId></ArticleIdList></Reference><Reference><Citation>Bopegamage S., Kovacova J., Vargova A., Motusova J., Petrovicova A., Benkovicova M., Gomolcak P., Bakkers J., Van Kuppeveld F., Melchers W.J.G., et al. Coxsackie B virus infection of mice: Inoculation by the oral route protects the pancreas from damage, but not from infection. J. Gen. Virol. 2005;86:3271–3280. doi: 10.1099/vir.0.81249-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81249-0</ArticleId><ArticleId IdType="pubmed">16298972</ArticleId></ArticleIdList></Reference><Reference><Citation>Bopegamage S., Borsanyiová M., Vargová A., Petrovicová A., Benkovicová M., Gomolcák P. Coxsackievirus infection of mice. I. Viral kinetics and histopathological changes in mice experimentally infected with coxsackieviruses B3 and B4 by oral route. Acta Virol. 2003;47:245–251.</Citation><ArticleIdList><ArticleId IdType="pubmed">15068380</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R., Mena I., Pagarigan R., Slifka M.K., Whitton J.L. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 2002;76:4430–4440. doi: 10.1128/JVI.76.9.4430-4440.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.9.4430-4440.2002</ArticleId><ArticleId IdType="pmc">PMC155066</ArticleId><ArticleId IdType="pubmed">11932410</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikarinen M., Tauriainen S., Honkanen T., Oikarinen S., Vuori K., Kaukinen K., Rantala I., Mäki M., Hyöty H. Detection of enteroviruses in the intestine of type 1 diabetic patients. Clin. Exp. Immunol. 2008;151:71–75. doi: 10.1111/j.1365-2249.2007.03529.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2007.03529.x</ArticleId><ArticleId IdType="pmc">PMC2276929</ArticleId><ArticleId IdType="pubmed">17991291</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikarinen M., Tauriainen S., Honkanen T., Vuori K., Karhunen P., Vasama-Nolvi C., Oikarinen S., Verbeke C., Blair G.E., Rantala I., et al. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia. 2008;51:1796–1802. doi: 10.1007/s00125-008-1107-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-008-1107-8</ArticleId><ArticleId IdType="pubmed">18696046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena I., Perry C.M., Harkins S., Rodriguez F., Gebhard J., Whitton J.L. The role of B lymphocytes in coxsackievirus B3 infection. Am. J. Pathol. 1999;155:1205–1215. doi: 10.1016/S0002-9440(10)65223-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)65223-6</ArticleId><ArticleId IdType="pmc">PMC1867001</ArticleId><ArticleId IdType="pubmed">10514403</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrath R., Bourlet T., Delézay O., Douche-Aourik F., Omar S., Aouni M., Pozzetto B. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line. J. Med. Virol. 2004;74:283–290. doi: 10.1002/jmv.20179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20179</ArticleId><ArticleId IdType="pubmed">15332278</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingel K., Stephan S., Sauter M., Zell R., McManus B.M., Bültmann B., Kandolf R. Pathogenesis of murine enterovirus myocarditis: Virus dissemination and immune cell targets. J. Virol. 1996;70:8888–8895. doi: 10.1128/jvi.70.12.8888-8895.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.70.12.8888-8895.1996</ArticleId><ArticleId IdType="pmc">PMC190986</ArticleId><ArticleId IdType="pubmed">8971018</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoop K.A., Miller M.J., Newberry R.D. Transepithelial antigen delivery in the small intestine: Different paths, different outcomes. Curr. Opin. Gastroenterol. 2013;29:112–118. doi: 10.1097/MOG.0b013e32835cf1cd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0b013e32835cf1cd</ArticleId><ArticleId IdType="pmc">PMC3697126</ArticleId><ArticleId IdType="pubmed">23380572</ArticleId></ArticleIdList></Reference><Reference><Citation>Reboldi A., Cyster J.G. Peyer’s patches: Organizing B-cell responses at the intestinal frontier. Immunol. Rev. 2016;271:230–245. doi: 10.1111/imr.12400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12400</ArticleId><ArticleId IdType="pmc">PMC4835804</ArticleId><ArticleId IdType="pubmed">27088918</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A., Kelsall B.L. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer’s patch dendritic cells. J. Immunol. 2001;166:4884–4890. doi: 10.4049/jimmunol.166.8.4884.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.8.4884</ArticleId><ArticleId IdType="pubmed">11290765</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Toyoda H., Linehan M., Iwasaki A., Nomoto A., Bernhardt G., Cello J., Wimmer E. Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation. J. Gen. Virol. 2014;95:1668–1676. doi: 10.1099/vir.0.064535-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.064535-0</ArticleId><ArticleId IdType="pmc">PMC4103066</ArticleId><ArticleId IdType="pubmed">24784416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>